Genelux (GNLX) EBITDA Margin (2022 - 2024)
Genelux (GNLX) posted EBITDA Margin of 101437.5% for Q1 2024, down 2568.58% on a QoQ basis from 3801.18% in Q1 2023, and down 9763632.0% year-over-year from N/an in Q2 2023.
Powered by 
Analysis
Genelux (GNLX) EBITDA Margin (2022 - 2024) Analysis & Trends
Genelux has reported EBITDA Margin for 3 years, with the latest figure at 101437.5% in Q1 2024.
- On a quarterly basis, EBITDA Margin fell 9763632.0% year-over-year to 101437.5% in Q1 2024; TTM through Dec 2024 was 396200.0%, a 38198529.0% decrease from a year earlier, with the FY2025 full-year figure at 415175.0%, down 1897500.0% from the prior year.
- EBITDA Margin was 101437.5% for Q1 2024 at Genelux, down from 3801.18% in the prior quarter.
- The five-year high for EBITDA Margin was 57.67% in Q3 2022, with the low at 101437.5% in Q1 2024.
- Average EBITDA Margin over 3 years is 27432.75%, with a median of 4175.59% recorded in 2023.
- The largest YoY upside for EBITDA Margin was 9763632 bps in 2024 against a maximum downside of 9763632 bps in 2024.
- Over 3 years, EBITDA Margin stood at 4550.0% in 2022, then rose by 16 bps to 3801.18% in 2023, then slumped by 2569 bps to 101437.5% in 2024.
- The last three EBITDA Margin figures came in at 101437.5% (Q1 2024), 3801.18% (Q1 2023), and 4550.0% (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.95% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -133.21% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 37.40% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 30.15% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 32.54% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -562.07% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 17.93% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -23.56% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -25,380.93% |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -101,437.50% |
| Mar 31, 2023 | -3,801.18% |
| Dec 31, 2022 | -4,550.00% |
| Sep 30, 2022 | 57.67% |